1,897 reports of this reaction
2.1% of all ZOLEDRONIC ACID reports
#11 most reported adverse reaction
ASTHENIA is the #11 most commonly reported adverse reaction for ZOLEDRONIC ACID, manufactured by Sandoz Inc. There are 1,897 FDA adverse event reports linking ZOLEDRONIC ACID to ASTHENIA. This represents approximately 2.1% of all 89,511 adverse event reports for this drug.
ZOLEDRONIC ACID has an overall safety score of 88 out of 100. Patients taking ZOLEDRONIC ACID who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHENIA is a less commonly reported adverse event for ZOLEDRONIC ACID, but still significant enough to appear in the safety profile.
In addition to asthenia, the following adverse reactions have been reported for ZOLEDRONIC ACID:
The following drugs have also been linked to asthenia in FDA adverse event reports:
ASTHENIA has been reported as an adverse event in 1,897 FDA reports for ZOLEDRONIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHENIA accounts for approximately 2.1% of all adverse event reports for ZOLEDRONIC ACID, making it a notable side effect.
If you experience asthenia while taking ZOLEDRONIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.